On July 22, 2025, the US Food and Drug Administration (FDA) started accepting applications to participate in the Commissioner’s National ...

We need a dedicated framework that clarifies the rules, requirements and incentives for those building personalized ...

FDA’s new guidance on AI in drug development centers the risk introduced by the technology The guidance is seen as the agency’s attempt at regulatory clarity, a key barrier to greater AI use Adobe ...